189 related articles for article (PubMed ID: 25301808)
1. 'N-of-1-pathways' unveils personal deregulated mechanisms from a single pair of RNA-Seq samples: towards precision medicine.
Gardeux V; Achour I; Li J; Maienschein-Cline M; Li H; Pesce L; Parinandi G; Bahroos N; Winn R; Foster I; Garcia JG; Lussier YA
J Am Med Inform Assoc; 2014; 21(6):1015-25. PubMed ID: 25301808
[TBL] [Abstract][Full Text] [Related]
2. Concordance of deregulated mechanisms unveiled in underpowered experiments: PTBP1 knockdown case study.
Gardeux V; Arslan AD; Achour I; Ho TT; Beck WT; Lussier YA
BMC Med Genomics; 2014; 7 Suppl 1(Suppl 1):S1. PubMed ID: 25079003
[TBL] [Abstract][Full Text] [Related]
3. Dynamic changes of RNA-sequencing expression for precision medicine: N-of-1-pathways Mahalanobis distance within pathways of single subjects predicts breast cancer survival.
Schissler AG; Gardeux V; Li Q; Achour I; Li H; Piegorsch WW; Lussier YA
Bioinformatics; 2015 Jun; 31(12):i293-302. PubMed ID: 26072495
[TBL] [Abstract][Full Text] [Related]
4. Interpreting personal transcriptomes: personalized mechanism-scale profiling of RNA-seq data.
Perez-Rathke A; Li H; Lussier YA
Pac Symp Biocomput; 2013; ():159-70. PubMed ID: 23424121
[TBL] [Abstract][Full Text] [Related]
5. Analysis of aggregated cell-cell statistical distances within pathways unveils therapeutic-resistance mechanisms in circulating tumor cells.
Schissler AG; Li Q; Chen JL; Kenost C; Achour I; Billheimer DD; Li H; Piegorsch WW; Lussier YA
Bioinformatics; 2016 Jun; 32(12):i80-i89. PubMed ID: 27307648
[TBL] [Abstract][Full Text] [Related]
6. Towards mechanism classifiers: expression-anchored Gene Ontology signature predicts clinical outcome in lung adenocarcinoma patients.
Yang X; Li H; Regan K; Li J; Huang Y; Lussier YA
AMIA Annu Symp Proc; 2012; 2012():1040-9. PubMed ID: 23304380
[TBL] [Abstract][Full Text] [Related]
7. Development of a RNA-Seq Based Prognostic Signature in Lung Adenocarcinoma.
Shukla S; Evans JR; Malik R; Feng FY; Dhanasekaran SM; Cao X; Chen G; Beer DG; Jiang H; Chinnaiyan AM
J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27707839
[TBL] [Abstract][Full Text] [Related]
8. Characterizing the impact of smoking and lung cancer on the airway transcriptome using RNA-Seq.
Beane J; Vick J; Schembri F; Anderlind C; Gower A; Campbell J; Luo L; Zhang XH; Xiao J; Alekseyev YO; Wang S; Levy S; Massion PP; Lenburg M; Spira A
Cancer Prev Res (Phila); 2011 Jun; 4(6):803-17. PubMed ID: 21636547
[TBL] [Abstract][Full Text] [Related]
9. Single-cell transcriptome analysis demonstrates inter-patient and intra-tumor heterogeneity in primary and metastatic lung adenocarcinoma.
Liu Y; Ye G; Huang L; Zhang C; Sheng Y; Wu B; Han L; Wu C; Dong B; Qi Y
Aging (Albany NY); 2020 Nov; 12(21):21559-21581. PubMed ID: 33170151
[TBL] [Abstract][Full Text] [Related]
10. Indel sensitive and comprehensive variant/mutation detection from RNA sequencing data for precision medicine.
Prodduturi N; Bhagwate A; Kocher JA; Sun Z
BMC Med Genomics; 2018 Sep; 11(Suppl 3):67. PubMed ID: 30255803
[TBL] [Abstract][Full Text] [Related]
11. Deregulation of small non-coding RNAs at the DLK1-DIO3 imprinted locus predicts lung cancer patient outcome.
Enfield KS; Martinez VD; Marshall EA; Stewart GL; Kung SH; Enterina JR; Lam WL
Oncotarget; 2016 Dec; 7(49):80957-80966. PubMed ID: 27829231
[TBL] [Abstract][Full Text] [Related]
12. A seven-long noncoding RNA signature predicts relapse in patients with early-stage lung adenocarcinoma.
Zhou H; Zhang H; Chen J; Cao J; Liu L; Guo C; Huang G; Zeng D
J Cell Biochem; 2019 Sep; 120(9):15730-15739. PubMed ID: 31050375
[TBL] [Abstract][Full Text] [Related]
13. N-of-1-pathways MixEnrich: advancing precision medicine via single-subject analysis in discovering dynamic changes of transcriptomes.
Li Q; Schissler AG; Gardeux V; Achour I; Kenost C; Berghout J; Li H; Zhang HH; Lussier YA
BMC Med Genomics; 2017 May; 10(Suppl 1):27. PubMed ID: 28589853
[TBL] [Abstract][Full Text] [Related]
14. Single-cell mRNA sequencing identifies subclonal heterogeneity in anti-cancer drug responses of lung adenocarcinoma cells.
Kim KT; Lee HW; Lee HO; Kim SC; Seo YJ; Chung W; Eum HH; Nam DH; Kim J; Joo KM; Park WY
Genome Biol; 2015 Jun; 16(1):127. PubMed ID: 26084335
[TBL] [Abstract][Full Text] [Related]
15. Individualized identification of disease-associated pathways with disrupted coordination of gene expression.
Wang H; Cai H; Ao L; Yan H; Zhao W; Qi L; Gu Y; Guo Z
Brief Bioinform; 2016 Jan; 17(1):78-87. PubMed ID: 26023086
[TBL] [Abstract][Full Text] [Related]
16. Proteogenomic Study beyond Chromosome 9: New Insight into Expressed Variant Proteome and Transcriptome in Human Lung Adenocarcinoma Tissues.
Kim YI; Lee J; Choi YJ; Seo J; Park J; Lee SY; Cho JY
J Proteome Res; 2015 Dec; 14(12):5007-16. PubMed ID: 26584007
[TBL] [Abstract][Full Text] [Related]
17. Unique microRNAs in lung adenocarcinoma groups according to major TKI sensitive EGFR mutation status.
Pak MG; Lee CH; Lee WJ; Shin DH; Roh MS
Diagn Pathol; 2015 Jul; 10():99. PubMed ID: 26170125
[TBL] [Abstract][Full Text] [Related]
18. Prognostic and Chemotherapy Predictive Value of Gene-Expression Phenotypes in Primary Lung Adenocarcinoma.
Ringnér M; Jönsson G; Staaf J
Clin Cancer Res; 2016 Jan; 22(1):218-29. PubMed ID: 26265693
[TBL] [Abstract][Full Text] [Related]
19. Multivariate models from RNA-Seq SNVs yield candidate molecular targets for biomarker discovery: SNV-DA.
Paul MR; Levitt NP; Moore DE; Watson PM; Wilson RC; Denlinger CE; Watson DK; Anderson PE
BMC Genomics; 2016 Mar; 17():263. PubMed ID: 27029813
[TBL] [Abstract][Full Text] [Related]
20. Single sample expression-anchored mechanisms predict survival in head and neck cancer.
Yang X; Regan K; Huang Y; Zhang Q; Li J; Seiwert TY; Cohen EE; Xing HR; Lussier YA
PLoS Comput Biol; 2012 Jan; 8(1):e1002350. PubMed ID: 22291585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
